
News
RIVM modelling for COVID-19 reviewed by international experts

An international audit committee of scientific experts, commissioned by the RIVM Scientific Advisory Board, reviewed the institute’s COVID-19 data analytics and modelling work. These models and data formed a scientific basis for recommendations by the Outbreak Management Team (OMT) and others on COVID-19 control measures in the Netherlands.
COVID-19 vaccination for risk groups: over-60s, flu vaccine group, care workers and pregnant women

From 19 September 2023 on, the first people will receive an invitation for COVID-19 vaccination. The first invitations will be sent by RIVM to people aged 60 years and older.
More news
- Sizable decrease in greenhouse gas emissions in 2022
- Sustainable agriculture: stimulate the creation of arable field margins through a more equal distribution of costs and benefits
- Gastrointestinal symptoms on the rise, but still fewer than before the COVID-19 pandemic
- RIVM creates risk assessment toolbox to assess local groundwater quality
- Offshore wind turbines: coating potentially harmful to environment
- Upward trend in required number of ambulances on working days discontinues
Featured topics
Recent publications
- Registration of food-related outbreaks in the Netherlands, 2022
- Review of the third party risk model for airports in the Netherlands. Transferability and scientific value
- Monitoring of radioactivity in the Netherlands. Air dust and deposition – results 2020 and 2021
- Monitoring of radioactivity in the Netherlands. National Radioactivity Monitoring Network – results 2020 and 2021
- Monitoring of radioactivity in the Netherlands. Milk, Food and Feed – results 2020 and 2021
- Monitoring of radioactivity in the Netherlands. Surface water and seawater – results 2020 and 2021
- Social cost-benefit analysis of field margins in the Hoeksche Waard, the Netherlands
- Annual report 2022 on enteric infections and zoonoses
- Comparative measurements with affordable DIY-noise meters